BJ's Restaurants exec granted RSUs and 10,566 options with 2035 expiry
Rhea-AI Filing Summary
Jennifer A. Jaffe, EVP & Chief People Officer of BJ's Restaurants, Inc. (BJRI), reported equity awards and option grants executed on 07/15/2025. The filing shows an acquisition of 7,557 restricted stock units (RSUs) that vest in three equal annual installments beginning July 15, 2026, representing a contingent right to one share each. It also reports a non-qualified stock option grant for 10,566 shares with an exercise price of $39.70, exercisable beginning July 15, 2026 and expiring July 15, 2035. Following the reported transactions, Ms. Jaffe beneficially owns 7,557 unvested RSUs and 10,566 options, all held directly.
Positive
- Executive alignment: Grants vest over multiple years, supporting retention and long‑term incentives.
- Clear vesting schedule: RSUs vest in three equal annual installments; options vest ~33.3% per year beginning 07/15/2026.
- Long exercise window: Options expire on 07/15/2035, providing a long timeframe for value realization.
Negative
- None.
Insights
TL;DR: Executive received time‑vesting RSUs and long‑dated options, aligning compensation with multi‑year retention and performance.
The awards are structured with multi‑year vesting (RSUs vesting in three annual installments; options vesting ~33.3% per year starting July 15, 2026), which supports retention and incentives to deliver longer‑term operational performance. The exercise price of $39.70 for the options sets the baseline for any future realized gain and the expiration in 2035 provides a long runway for value creation. These grants are standard for senior executives and signal management alignment with shareholder interests without immediate dilution from vested shares.
TL;DR: The disclosure is a routine insider compensation filing; it provides limited near‑term market impact but signals executive commitment.
The Form 4 documents compensation‑related equity rather than open‑market purchases or sales, so direct market impact is likely muted. The reported quantities—7,557 RSUs and 10,566 options—are modest relative to large‑cap share counts but meaningful for executive alignment. Investors should note vesting schedules and exercise price as they affect future dilution timing and potential incentive realization.